Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Targeting Sellers of Pure Caffeine Powder

By Pharmaceutical Processing | December 23, 2014

WASHINGTON (AP) — The Food and Drug Administration is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses.

The FDA warned consumers to avoid pure powdered caffeine this summer after the death of an Ohio teen. Some major retailers have stopped selling it in bulk, but the substance is still widely available on the Internet and in some stores.

Even a teaspoon of the powder can be lethal — it is equivalent to 25 cups of coffee. Some teenagers and young adults have been particularly drawn to the powder for its perceived energy boost.

Eighteen-year-old Logan Stiner of LaGrange, Ohio, died in May after consuming it. It was also linked to the death of a Georgia man this year.

Caffeine powder is usually marketed as a dietary supplement and is unregulated, unlike caffeine added to soda. Since the FDA doesn’t have the legal authority to just pull such a substance off the shelves, the agency is in process of building a legal case against those who are marketing it in bulk in an attempt to persuade them to stop.

Michael Taylor, FDA’s deputy commissioner of foods, said in an interview with The Associated Press Monday that it is “inherently irresponsible” to market such a potentially dangerous product.

“I would hope that people would get the message that they just ought to stop selling it,” Taylor said.

The agency will “pursue all legal options” against those who don’t, he said. He did not give a timeline for legal action.

The FDA has said that people may not realize the powdered form is a pure chemical, and that the difference between a safe amount and a lethal dose is very small.

Symptoms of caffeine overdose or toxicity include rapid or erratic heartbeat, seizures, vomiting, diarrhea and disorientation.

Stiner’s parents visited Washington earlier this month to lobby for more regulatory oversight.

“Before May 27, 2014, we had never heard of ‘caffeine powder.’ Now we think about it every day,” Dennis and Katie Stiner said in a meeting with lawmakers.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE